Additive Benefits of Pravastatin and Aspirin to Decrease Risks of Cardiovascular Disease

Discussion in 'Health and medical' started by listener, Mar 2, 2004.

  1. listener

    listener Guest

    http://archinte.ama-assn.org/cgi/content/abstract/164/1/40?maxtoshow=

    "In randomized trials of secondary prevention, pravastatin sodium and aspirin reduce risks of
    cardiovascular disease. Pravastatin has a predominantly delayed antiatherogenic effect, and aspirin
    has an immediate antiplatelet effect, raising the possibility of additive clinical benefits. "

    ...

    "More widespread and appropriate combined use of statins and aspirin in secondary prevention of
    cardiovascular disease will avoid large numbers of premature deaths. "

    L.
     
    Tags:


Loading...